LifeVantage Unveils Turnaround Plan to Rebuild Brand, Margins and Growth

Lifevantage NASDAQ: LFVN executives outlined a turnaround plan centered on strengthening the company’s brand, improving consumer relevance and increasing operating efficiency during a Water Tower Research conference discussion. President and CEO Terrence Moorehead, who recently joined the company, said LifeVantage differentiates itself from conventional supplement companies through products designed to support the body’s own processes rather than simply add ingredients. He highlighted the company’s Protandim product line, including Nrf2 for cellular defense, Nrf1 for cellular energy and an NAD product positioned around longevity. Moorehead said the company needs to communicate the products’ benefits and clinical support more effectively. “We’re not maximizing the language behind it,” he said, adding that LifeVantage needs to improve its messaging, packaging, digital advertising and social-media presence. Consumer Relevance and Product Positioning Moorehead said the company sees opportunities to update product positioning and price points while protecting its historically high gross margins. He said certain products may require reformulation or repackaging to fit target price categories. He also discussed the company’s MindBody GLP-1 System, which experienced substantial initial demand in fiscal 2025 before sales declined in fiscal 2026. Moorehead attributed the decline partly to a natural progression following product launch, with some customers continuing to use the product and others moving away from it. He also cited increasing competition, declining prices for GLP-1 products and new product formats entering the market. According to Moorehead, LifeVantage did not respond quickly enough to competitive developments and did not generate sufficient new-customer acquisition to sustain the product’s earlier sales levels. He said management expects to focus over the next 12 months on improving MindBody’s pricing, positioning and customer access, potentially including greater use of digital and social-media channels. Margin and Efficiency Initiatives The company’s recent top-line deterioration over the past 12 to 18 months has reduced operating leverage, Moorehead said. He said the company is evaluating supply-chain initiatives, organizational structure, technology and automation to support profitability without relying solely on cost cuts. “We’re not going to cut our way to success,” Moorehead said. “We’re going to grow our way to success.” CFO Carl Aure said LifeVantage reduced selling, general and administrative expenses by nearly $10 million, or about 15%, despite a year-over-year revenue decline. However, he said the reductions were not sufficient to fully offset the impact of lower revenue. Aure said the company is focused on restoring gross margin to above 80%, including through a review of logistics operations. He said LifeVantage is also looking for further SG&A savings through technology and operating efficiencies. Moorehead said management wants a “smarter and more powerful organization,” including more frequent engagement with the company’s sales force through less costly technology-enabled formats. He also pointed to potential applications for automation and artificial intelligence. Supply Chain and International Growth LifeVantage uses an outsourced, asset-light manufacturing model. Aure said most international markets are supplied through U.S.-based third-party contract manufacturers, though the company sources certain products locally for Japan. Moorehead said the company could explore local sourcing in markets such as Mexico, where consumers may be especially price sensitive. Local sourcing...